644 related articles for article (PubMed ID: 17503577)
21. Pathophysiology and treatment of hepatorenal syndrome.
Wong F; Blendis L
Gastroenterologist; 1998 Jun; 6(2):122-35. PubMed ID: 9660529
[TBL] [Abstract][Full Text] [Related]
22. Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis.
Gentilini P; Laffi G; La Villa G; Raggi VC
Ann Ital Med Int; 1999; 14(4):264-84. PubMed ID: 10638019
[TBL] [Abstract][Full Text] [Related]
23. Terlipressin in hepatorenal syndrome: Evidence for present indications.
Rajekar H; Chawla Y
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():109-14. PubMed ID: 21199521
[TBL] [Abstract][Full Text] [Related]
24. Treatment of hepatorenal syndrome.
Kiser TH; Maclaren R; Fish DN
Pharmacotherapy; 2009 Oct; 29(10):1196-211. PubMed ID: 19792993
[TBL] [Abstract][Full Text] [Related]
25. Hepatorenal syndrome.
Gattoni A; Marotta F; Vangieri B; Pisani G; Cristiano F
Clin Ter; 2004 Sep; 155(9):375-89. PubMed ID: 15700631
[TBL] [Abstract][Full Text] [Related]
26. Review article: hepatorenal syndrome--how to assess response to treatment and nonpharmacological therapy.
Arroyo V
Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():49-54; discussion 55-6. PubMed ID: 15335402
[TBL] [Abstract][Full Text] [Related]
27. Hepatorenal syndrome.
Guevara M; Ginès P
Dig Dis; 2005; 23(1):47-55. PubMed ID: 15920325
[TBL] [Abstract][Full Text] [Related]
28. Review article: Management of ascites and associated complications in patients with cirrhosis.
Kuiper JJ; de Man RA; van Buuren HR
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():183-93. PubMed ID: 18081661
[TBL] [Abstract][Full Text] [Related]
29. Renal failure in patients with cirrhosis: hepatorenal syndrome and renal support strategies.
Meltzer J; Brentjens TE
Curr Opin Anaesthesiol; 2010 Apr; 23(2):139-44. PubMed ID: 20124895
[TBL] [Abstract][Full Text] [Related]
30. Hepatorenal syndrome: pathophysiology and treatment.
Pandey CK; Singh N; Kumar V; Agarwal A; Baronia AK; Gaur A; Singh PK; Singh S
J Assoc Physicians India; 2002 Jun; 50():819-25. PubMed ID: 12240852
[TBL] [Abstract][Full Text] [Related]
31. Fluid retention in cirrhosis: pathophysiology and management.
Kashani A; Landaverde C; Medici V; Rossaro L
QJM; 2008 Feb; 101(2):71-85. PubMed ID: 18184668
[TBL] [Abstract][Full Text] [Related]
32. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion.
Guevara M; Ginès P; Fernández-Esparrach G; Sort P; Salmerón JM; Jiménez W; Arroyo V; Rodés J
Hepatology; 1998 Jan; 27(1):35-41. PubMed ID: 9425914
[TBL] [Abstract][Full Text] [Related]
33. [Hepatorenal syndrome].
Mancini E
G Ital Nefrol; 2012; 29(5):563-78. PubMed ID: 23117737
[TBL] [Abstract][Full Text] [Related]
34. [Hepatorenal syndrome: pathogenesis and treatment].
Ashkenazi E; Ilan Y; Shoval D
Harefuah; 2007 Jun; 146(6):475-9, 499. PubMed ID: 17760404
[TBL] [Abstract][Full Text] [Related]
35. TIPS or vasoconstrictors for the treatment of hepatorenal syndrome type 1--effect on survival?
Gülberg V; Gerbes AL
Z Gastroenterol; 2002 Sep; 40(9):823-6. PubMed ID: 12215953
[TBL] [Abstract][Full Text] [Related]
36. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide.
Angeli P; Volpin R; Gerunda G; Craighero R; Roner P; Merenda R; Amodio P; Sticca A; Caregaro L; Maffei-Faccioli A; Gatta A
Hepatology; 1999 Jun; 29(6):1690-7. PubMed ID: 10347109
[TBL] [Abstract][Full Text] [Related]
37. [Hepatorenal syndrome].
Pŭrvanov P
Khirurgiia (Sofiia); 2002; 58(2):34-9. PubMed ID: 12515019
[TBL] [Abstract][Full Text] [Related]
38. Hepatorenal syndrome.
Ginès P; Guevara M; Arroyo V; Rodés J
Lancet; 2003 Nov; 362(9398):1819-27. PubMed ID: 14654322
[TBL] [Abstract][Full Text] [Related]
39. Hepatorenal syndrome: a severe, but treatable, cause of kidney failure in cirrhosis.
Fagundes C; Ginès P
Am J Kidney Dis; 2012 Jun; 59(6):874-85. PubMed ID: 22480795
[TBL] [Abstract][Full Text] [Related]
40. The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond.
Moreau R; Lebrec D
Hepatology; 2006 Mar; 43(3):385-94. PubMed ID: 16496352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
